E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/28/2017 in the Prospect News Structured Products Daily.

New Issue: Morgan Stanley sells $10.06 million 15% contingent income autocalls tied to ETFs

By Wendy Van Sickle

Columbus, Ohio, Nov. 28 – Morgan Stanley Finance LLC priced $10.06 million of contingent income autocallable securities due Nov. 25, 2019 linked to the worst performing of the SPDR S&P Bank ETF, the SPDR S&P Biotech ETF and the Technology Select Sector SPDR Fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 15% if each fund closes at or above its 72.83% downside threshold on the determination date that quarter.

The notes will be called at par plus the contingent coupon if each fund closes at or above its initial level on any determination date other than the final date.

The payout at maturity will be par unless any fund finishes below its 72.83% downside threshold, in which case investors will be fully exposed to any losses of the worst performing fund.

The notes are guaranteed by Morgan Stanley.

Morgan Stanley & Co. LLC is the agent with distribution through Morgan Stanley Wealth Management.

Issuer:Morgan Stanley Finance LLC
Guarantor:Morgan Stanley
Issue:Contingent income autocallable securities
Underlying funds:SPDR S&P Bank ETF, SPDR S&P Biotech ETF and Technology Select Sector SPDR Fund
Amount:$10.06 million
Maturity:Nov. 25, 2019
Coupon:15% per year, payable quarterly if each fund closes at or above downside threshold on determination date that quarter
Price:Par
Payout at maturity:If each fund finishes at or above downside threshold, par; otherwise, 1% loss for each 1% decline of worse performing fund
Call:At par if each fund closes at or above initial level on any quarterly call date other than final date
Initial levels:$80.87 for Biotech, $45.29 for Bank, $63.59 for Technology
Downside thresholds:$58.898 for Biotech, $32.985 for Bank, $46.313 for Technology, 72.83% of initial levels
Pricing date:Nov. 20
Settlement date:Nov. 24
Agent:Morgan Stanley & Co. LLC with Morgan Stanley Wealth Management as a distributor
Fees:1.75%
Cusip:61768CUK1

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.